celecoxib has been researched along with Premature Birth in 3 studies
Premature Birth: CHILDBIRTH before 37 weeks of PREGNANCY (259 days from the first day of the mother's last menstrual period, or 245 days after FERTILIZATION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To analyse the expression of 15 genes encoding receptors and enzymes associated with the molecular mechanism of the tocolytic drugs atosiban (oxytocin receptor antagonist), nifedipine (calcium channel blocker) and celecoxib (selective cyclo-oxygenase-2 inhibitor) in preterm labor patients with premature rupture of fetal membranes in relation to symptoms of intrauterine infection and preterm labor risk factors." | 3.78 | Expression of selected genes in preterm premature rupture of fetal membranes. ( Chyczewski, L; Kowalczuk, O; Kuć, P; Laudański, P; Laudański, T, 2012) |
| " Strikingly, uterine deletion of Trp53 increased the incidence of preterm birth, a condition that was corrected by oral administration of the selective COX2 inhibitor celecoxib." | 3.76 | Uterine-specific p53 deficiency confers premature uterine senescence and promotes preterm birth in mice. ( Bradshaw, HB; Daikoku, T; Dey, SK; Hirota, Y; Tranguch, S; Xie, H, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cha, J | 1 |
| Bartos, A | 1 |
| Egashira, M | 1 |
| Haraguchi, H | 1 |
| Saito-Fujita, T | 1 |
| Leishman, E | 1 |
| Bradshaw, H | 1 |
| Dey, SK | 2 |
| Hirota, Y | 2 |
| Daikoku, T | 1 |
| Tranguch, S | 1 |
| Xie, H | 1 |
| Bradshaw, HB | 1 |
| Kuć, P | 1 |
| Laudański, P | 1 |
| Kowalczuk, O | 1 |
| Chyczewski, L | 1 |
| Laudański, T | 1 |
3 other studies available for celecoxib and Premature Birth
| Article | Year |
|---|---|
Combinatory approaches prevent preterm birth profoundly exacerbated by gene-environment interactions.
Topics: 20-Hydroxysteroid Dehydrogenases; Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; | 2013 |
Uterine-specific p53 deficiency confers premature uterine senescence and promotes preterm birth in mice.
Topics: Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Decidua; Dinoprost; Embryo Implan | 2010 |
Expression of selected genes in preterm premature rupture of fetal membranes.
Topics: Adult; Calcium Channel Blockers; Calcium Channels, L-Type; Celecoxib; Cyclooxygenase 2 Inhibitors; D | 2012 |